Re: Maria J. Ribal, Philip Cornford, Alberto Briganti, et al. European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to A...

por Thomas, Christian, Grüllich, Carsten, Erb, Holger H.H.
Publicado 2020

Interleukin‐4 induces a CD44(high)/CD49b(high) PC3 subpopulation with tumor‐initiating characteristics

por Erb, Holger H.H., Guggenberger, Fabian, Santer, Frédéric R., Culig, Zoran
Publicado 2018

Impact of STAT Proteins in Tumor Progress and Therapy Resistance in Advanced and Metastasized Prostate Cancer

por Ebersbach, Celina, Beier, Alicia-Marie K., Thomas, Christian, Erb, Holger H. H.
Publicado 2021

Retroperitoneal lymph node dissection for testicular cancer is a demanding procedure: detailed real-life data of complications and additional surgical procedures in 295 cases

por Latarius, Stefanie, Leike, Steffen, Erb, Holger, Putz, Juliane, Borkowetz, Angelika, Thomas, Christian, Baunacke, Martin
Publicado 2023

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways

por Oh, Su Jung, Erb, Holger H H, Hobisch, Alfred, Santer, Frédéric R, Culig, Zoran
Publicado 2012

Metabolic changes during prostate cancer development and progression

por Beier, Alicia-Marie K., Puhr, Martin, Stope, Matthias B., Thomas, Christian, Erb, Holger H. H.
Publicado 2022

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?

por Thomas, Christian, Baunacke, Martin, Erb, Holger H. H., Füssel, Susanne, Erdmann, Kati, Putz, Juliane, Borkowetz, Angelika
Publicado 2021

PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target

por Erb, Holger Hans Hermann, Ebert, Marlies, Kuhn, Ronja, Donix, Lukas, Haferkamp, Axel, Seed, Robert Ian, Jüngel, Eva
Publicado 2019

Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

por Donix, Lukas, Erb, Holger H. H., Peitzsch, Claudia, Dubrovska, Anna, Pfeifer, Manuel, Thomas, Christian, Fuessel, Susanne, Erdmann, Kati
Publicado 2022

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity

por Siciliano, Tiziana, Sommer, Ulrich, Beier, Alicia-Marie K., Stope, Matthias B., Borkowetz, Angelika, Thomas, Christian, Erb, Holger H. H.
Publicado 2022

Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer Tissue

por Sommer, Ulrich, Ebersbach, Celina, Beier, Alicia-Marie K., Baretton, Gustavo B., Thomas, Christian, Borkowetz, Angelika, Erb, Holger H. H.
Publicado 2022

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines

por Linke, Dinah, Donix, Lukas, Peitzsch, Claudia, Erb, Holger H. H., Dubrovska, Anna, Pfeifer, Manuel, Thomas, Christian, Fuessel, Susanne, Erdmann, Kati
Publicado 2022

Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers

por Rane, Jayant K., Erb, Holger H.H., Nappo, Giovanna, Mann, Vincent M., Simms, Matthew S., Collins, Anne T., Visakorpi, Tapio, Maitland, Norman J.
Publicado 2016

Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular Efficacy

por Nitsch, Andreas, Sander, Caroline, Eggers, Benedikt, Weiss, Martin, Egger, Eva, Kramer, Franz-Josef, Erb, Holger H. H., Mustea, Alexander, Stope, Matthias B.
Publicado 2023

A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response

por Siciliano, Tiziana, Simons, Ingo H., Beier, Alicia-Marie K., Ebersbach, Celina, Aksoy, Cem, Seed, Robert I., Stope, Matthias B., Thomas, Christian, Erb, Holger H. H.
Publicado 2021

Influence of Systemic Therapy on the Expression and Activity of Selected STAT Proteins in Prostate Cancer Tissue

por Ebersbach, Celina, Beier, Alicia-Marie K., Hönscheid, Pia, Sperling, Christian, Jöhrens, Korinna, Baretton, Gustavo B., Thomas, Christian, Sommer, Ulrich, Borkowetz, Angelika, Erb, Holger H. H.
Publicado 2022

Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells

por Sommer, Ulrich, Siciliano, Tiziana, Ebersbach, Celina, Beier, Alicia-Marie K., Stope, Matthias B., Jöhrens, Korinna, Baretton, Gustavo B., Borkowetz, Angelika, Thomas, Christian, Erb, Holger H. H.
Publicado 2022

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

por Erb, Holger H. H., Bodenbender, Julia, Handle, Florian, Diehl, Tamara, Donix, Lukas, Tsaur, Igor, Gleave, Martin, Haferkamp, Axel, Huber, Johannes, Fuessel, Susanne, Juengel, Eva, Culig, Zoran, Thomas, Christian
Publicado 2020

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα(2) through IRF9

por Erb, Holger H H, Langlechner, Regina V, Moser, Patrizia L, Handle, Florian, Casneuf, Tineke, Verstraeten, Karin, Schlick, Bettina, Schäfer, Georg, Hall, Brett, Sasser, Kate, Culig, Zoran, Santer, Frédéric R
Publicado 2013

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

por Vakhrusheva, Olesya, Erb, Holger H. H., Bräunig, Vitus, Markowitsch, Sascha D., Schupp, Patricia, Baer, Patrick C., Slade, Kimberly Sue, Thomas, Anita, Tsaur, Igor, Puhr, Martin, Culig, Zoran, Cinatl, Jindrich, Michaelis, Martin, Efferth, Thomas, Haferkamp, Axel, Juengel, Eva
Publicado 2022